Cited by 53Aldose Reductase and TaurineSteroid Chemistry and BiochemistryPharmacogenetics and Drug Metabolism

Human Cytosolic Hydroxysteroid Dehydrogenases of the Aldo-ketoreductase Superfamily Catalyze Reduction of Conjugated Steroids

Open access
Jin, Yi, Duan, Ling, Lee, Seon Hwa, Kloosterboer, Helenius J., Blair, Ian A., Penning, Trevor M.·2009·Journal of Biological Chemistry

Abstract

Aldo-ketoreductase 1C (AKR1C) enzymes catalyze the NADPH-dependent reduction of ketosteroids to hydroxysteroids. They are Phase I metabolizing enzymes for natural and synthetic steroid hormones. They convert 5alpha-dihydrotestosterone (Dht, potent androgen) to 3alpha/beta-androstanediols (inactive androgens) and the prodrug tibolone (Tib) to estrogenic 3alpha/beta-hydroxytibolones. Herein we demonstrate for the first time that human AKR1C enzymes (AKR1C1-4) are able to reduce conjugated steroids such as Dht-17beta-glucuronide (DhtG), Dht-17beta-sulfate (DhtS), and Tib-17beta-sulfate (TibS). Product identities were characterized by liquid chromatography-mass spectrometry, and kinetic parameters of the reactions were determined. The product profile of the reduction of each steroid conjugate by the individual AKR1C isoform was similar to that of the corresponding free steroid except for the reduction of DhtG catalyzed by AKR1C2, where a complete inversion in stereochemical preference to 3beta-reduction (with DhtG) from 3alpha-reduction (with Dht and DhtS) was observed. The catalytic efficiency of 3-keto reduction was modestly affected by the presence of a 17-sulfate group but severely impaired by the presence of a 17-glucuronide group for AKR1C1-3 isoforms. AKR1C4, however, showed superior catalytic efficiencies versus the other isoforms, and those were unaffected by steroid conjugation. Our findings provide evidence for alternative pathways of steroid metabolism where the phase I reaction (reduction) occurs after the phase II reaction (conjugation). Specifically, it is indicated that Dht is metabolized to its metabolite 3alpha-androstanediol-17-glucuronide via the previously unrecognized "conjugation pathway" involving the sequential reactions of UGT2B17 and AKR1C4 in liver but via the conventional "reduction pathway" involving the sequential reactions of AKR1C2 and UGT2B15/17 in prostate.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m809465200

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AKR1 enzymes act on conjugated steroids and on synthetic therapeutic steroids.

    “In addition, these enzymes act on conjugated steroids and synthetic steroids used as therapeutics”
  • AKR1C1, AKR1C2 and AKR1C3 form mainly 3β-hydroxy-5α-androstane-17β-glucuronide, whereas AKR1C4 preferentially forms the corresponding 3α-stereoisomer.

    “AKR1C1, AKR1C2 and AKR1C3 form mainly 3β-hydroxy-5α-androstane-17β-glucuronide whereas AKR1C4 preferentially forms the corresponding 3α-stereoisomer.”
  • AKR1C1 and AKR1C2 prefer sulfate over bulky glucuronide conjugates, with AKR1C2 being the more efficient enzyme.

    “By contrast, AKR1C1 and AKR1C2 prefer sulfate to bulky glucuronide conjugates where AKR1C2 is the more efficient enzyme”
  • AKR1C enzymes act on conjugated steroids, suggesting an alternative route in which the steroid is conjugated first at the 17β-position and then reduced at the 3-position.

    “Recently AKR1C enzymes were shown to act on conjugated steroids (Table 3) [10], which suggested an alternative route where the steroid is conjugated first at the 17β-position and then reduced at the 3-position.”
  • Among AKR1C enzymes, AKR1C4 has by far the highest catalytic efficiency for reduction of 5α-DHT-17β-glucuronide or sulfate, while AKR1C3 has a low kcat for this reaction.

    “Among AKR1C enzymes, AKR1C4 has by far the highest catalytic efficiency for reduction of 5α-DHT-17β-glucuronide or sulfate. AKR1C3 has a low kcat for this reaction.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Weihua, Z., Lathe, R., Warner, M., and Gustafsson, J. A. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 13589 -13594

Cited by

Sorted by citations

Authors
Jin, Y., Duan, L., Lee, S. H., Kloosterboer, H. J., Blair, I. A., & Penning, T. M.
Affiliations
  • University of Pennsylvania (US)
  • Organon (Netherlands) (NL)
Corresponding author
Penning, Trevor M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2009-04
Volume
284
Issue
15
Pages
10013-10022
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2065251992
Cited by
50
References
42
Citations by year
2026: 1 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 1 · 2019: 1 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 4
FWCI
2.37
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (R01 CA 90744, R01CA090744)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK47015, R01DK047015)
  • National Institute of Environmental Health Sciences (P30 ES015857)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Steroid Chemistry and Biochemistry
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
steroid conjugates, dihydrotestosterone, tibolone, steroid metabolism, UGT2B17, UGT2B15, phase I metabolism, phase II metabolism, androgen metabolism, enzyme kinetic parameters
MeSH terms
Binding Sites, Catalysis, Chromatography, Liquid, Cytosol, Hormones, Humans, Hydroxysteroid Dehydrogenases, Kinetics, Liver, Models, Chemical, Molecular Conformation, Mass Spectrometry, Steroids, Crystallography, X-Ray, Protein Isoforms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review